CCM
SGHT icon

Cinctive Capital Management’s Sight Sciences SGHT Stock Holding History

Cinctive Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-85,100
Closed -$765K – 594
2022
Q2 		$765K Sell
85,100
-53,900
-39% -$474K 0.03% 418
2022
Q1 		$1.61M Buy
139,000
+62,000
+81% +$954K 0.06% 347
2021
Q4 		$1.35M Buy
+77,000
New +$1.69M 0.06% 360

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cinctive Capital Management's SGHT Position: Q3 2022 in Review

Cinctive Capital Management sold out of Sight Sciences (SGHT) in Q3 2022, closing a stake of 85,100 shares — an estimated $765K sold.

Cinctive Capital Management first reported a position in SGHT in Q4 2021 and held it in 3 quarters. The position peaked at $1.61M in Q1 2022. 68 funds tracked by Wall St. Rank hold SGHT as of Q3 2022.

  • Cinctive Capital Management reported no remaining Sight Sciences position as of Q3 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 85,100 Sight Sciences shares in Q3 2022, an estimated $765K.
  • Cinctive Capital Management first reported a position in Sight Sciences in Q4 2021 and held it in 3 quarters.
  • Cinctive Capital Management's Sight Sciences position peaked at $1.61M in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2022.

Based on Cinctive Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.